EV-to-EBITDA is calculated as enterprise value divided by its EBITDA. As of today, Global Health's enterprise value is ₹371,675 Mil.
Global Health's EBITDA for the trailing twelve months (TTM) ended in Dec. 2023 was ₹8,585 Mil. Therefore, Global Health's EV-to-EBITDA for today is 43.29.
The historical rank and industry rank for Global Health's EV-to-EBITDA or its related term are showing as below:
BOM:543654'
s EV-to-EBITDA Range Over the Past 10 Years
Min: 18.65 Med: 25.49 Max: 46.49
Current: 43.29
During the past 4 years, the highest EV-to-EBITDA of Global Health was 46.49. The lowest was 18.65. And the median was 25.49.
BOM:543654's EV-to-EBITDA is ranked worse than 91.34% of 462
companies
in the Healthcare Providers & Services industry
Industry Median: 12.88
vs BOM:543654: 43.29
EV-to-EBITDA is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.
The "classic" EV-to-EBITDA is much better in capturing debt and net cash than the PE Ratio.
Global Health EV-to-EBITDA Historical Data
The historical data trend for Global Health's EV-to-EBITDA can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Competitive Comparison of Global Health's EV-to-EBITDA
For the Medical Care Facilities subindustry, Global Health's EV-to-EBITDA, along with its competitors' market caps and EV-to-EBITDA data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Global Health's EV-to-EBITDA Distribution in the Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, Global Health's EV-to-EBITDA distribution charts can be found below:
* The bar in red indicates where Global Health's EV-to-EBITDA falls into.
Global Health EV-to-EBITDA Calculation
Global Health's EV-to-EBITDA for today is calculated as:
Global Health's current Enterprise Value is ₹371,675 Mil.
Global Health's EBITDA for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was ₹8,585 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Global Health (BOM:543654) EV-to-EBITDA Explanation
EV-to-EBITDA is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.
Global Health's PE Ratio for today is calculated as:
Global Health's share price for today is ₹1392.30.
Global Health's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was ₹16.850.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Study has found that the companies with the lowest EV-to-EBITDA outperforms companies measured as cheap by other ratios such as PE Ratio.
Thank you for viewing the detailed overview of Global Health's EV-to-EBITDA provided by GuruFocus.com. Please click on the following links to see related term pages.
Global Health Ltd operates as a private multi-specialty tertiary care provider operating in the North and East regions of India, with key specialties of cardiology and cardiac science, neurosciences, oncology, digestive and hepatobiliary sciences, orthopedics, liver transplant, and kidney and urology. Under the Medanta brand, it has a network of hospitals in operation (Gurugram, Indore, Ranchi, and Lucknow), a hospital that is under construction with an operational outpatient facility (Patna), and a hospital (Noida) planned for development. The Group operates Healthcare services as a single business segment in India, constituting a single geographical segment.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
BOM:543654 has been successfully added to your 